APO Research
Talk to an analyst

APO RESEARCH · REPORT

Third-Party Drug Testing Administration service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Third-Party Drug Testing Administration service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026194 pages

Choose your research edition.

Industry ResearchThird-Party Drug Testing Administration service Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Third-Party Drug Testing Administration service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Third-Party Drug Testing Administration service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Third-Party Drug Testing Administration service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Third-Party Drug Testing Administration service Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Third-Party Drug Testing Administration service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Third-Party Drug Testing Administration service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Third-Party Drug Testing Administration service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Third-Party Drug Testing Administration service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Third-Party Drug Testing Administration service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Third-Party Drug Testing Administration service include Lobdock, Info Cubic, Procom Testing, Midway, National Drug Screening, CO-OP Drug Testing, ADVANTAGECARE, CannAmm and Medway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Third-Party Drug Testing Administration service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Third-Party Drug Testing Administration service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Third-Party Drug Testing Administration service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Third-Party Drug Testing Administration service market size, projected growth trends, production technologies, key applications, and end-use industries.

Third-Party Drug Testing Administration service Segment by Company

Lobdock

Info Cubic

Procom Testing

Midway

National Drug Screening

CO-OP Drug Testing

ADVANTAGECARE

CannAmm

Medway

AMDT

WorkPlace Health

Global Verification Network

Mobile Medical Corporation

DRUG TESTING CORPORATION

Origin

Third-Party Drug Testing Administration service Segment by Type

Pre-Employment Drug Testing

Reasonable Suspicion Drug Testing

Random Drug Testing

Return-to-Duty Drug Testing

Post-Accident Drug Testing

Others

Third-Party Drug Testing Administration service Segment by Application

SMEs

Large Enterprise

Third-Party Drug Testing Administration service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Third-Party Drug Testing Administration service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Third-Party Drug Testing Administration service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Third-Party Drug Testing Administration service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Third-Party Drug Testing Administration service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Third-Party Drug Testing Administration service industry.

Chapter 3: Detailed analysis of Third-Party Drug Testing Administration service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Third-Party Drug Testing Administration servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Third-Party Drug Testing Administration service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Pre-Employment Drug Testing Table 3. Key Players of Reasonable Suspicion Drug Testing Table 4. Key Players of Random Drug Testing Table 3. Key Players of Return-to-Duty Drug Testing Table 4. Key Players of Post-Accident Drug Testing Table 5. Key Players of Others Table 6. Global Third-Party Drug Testing Administration service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of SMEs Table 8. Key Players of Large Enterprise Table 9. Global Third-Party Drug Testing Administration service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Third-Party Drug Testing Administration service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Third-Party Drug Testing Administration service Market Share by Region (2021-2026) Table 12. Global Third-Party Drug Testing Administration service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Third-Party Drug Testing Administration service Market Share by Region (2027-2032) Table 14. Third-Party Drug Testing Administration service Industry Trends Table 15. Third-Party Drug Testing Administration service Industry Drivers Table 16. Third-Party Drug Testing Administration service Industry Opportunities and Challenges Table 17. Third-Party Drug Testing Administration service Industry Restraints Table 18. Global Third-Party Drug Testing Administration service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Third-Party Drug Testing Administration service Revenue Market Share by Company (2021-2026) Table 20. Global Third-Party Drug Testing Administration service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Third-Party Drug Testing Administration service Key Company Head Office and Area Served Table 22. Global Third-Party Drug Testing Administration service Company, Product Type & Application Table 23. Global Third-Party Drug Testing Administration service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Third-Party Drug Testing Administration service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Third-Party Drug Testing Administration service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Third-Party Drug Testing Administration service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Third-Party Drug Testing Administration service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Third-Party Drug Testing Administration service Revenue Market Share by Type (2021-2026) Table 30. Global Third-Party Drug Testing Administration service Revenue Market Share by Type (2027-2032) Table 31. Global Third-Party Drug Testing Administration service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Third-Party Drug Testing Administration service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Third-Party Drug Testing Administration service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Third-Party Drug Testing Administration service Revenue Market Share by Application (2021-2026) Table 35. Global Third-Party Drug Testing Administration service Revenue Market Share by Application (2027-2032) Table 36. Lobdock Company Information Table 37. Lobdock Business Overview Table 38. Lobdock Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Lobdock Third-Party Drug Testing Administration service Product Portfolio Table 40. Lobdock Recent Development Table 41. Info Cubic Company Information Table 42. Info Cubic Business Overview Table 43. Info Cubic Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Info Cubic Third-Party Drug Testing Administration service Product Portfolio Table 45. Info Cubic Recent Development Table 46. Procom Testing Company Information Table 47. Procom Testing Business Overview Table 48. Procom Testing Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Procom Testing Third-Party Drug Testing Administration service Product Portfolio Table 50. Procom Testing Recent Development Table 51. Midway Company Information Table 52. Midway Business Overview Table 53. Midway Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Midway Third-Party Drug Testing Administration service Product Portfolio Table 55. Midway Recent Development Table 56. National Drug Screening Company Information Table 57. National Drug Screening Business Overview Table 58. National Drug Screening Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. National Drug Screening Third-Party Drug Testing Administration service Product Portfolio Table 60. National Drug Screening Recent Development Table 61. CO-OP Drug Testing Company Information Table 62. CO-OP Drug Testing Business Overview Table 63. CO-OP Drug Testing Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. CO-OP Drug Testing Third-Party Drug Testing Administration service Product Portfolio Table 65. CO-OP Drug Testing Recent Development Table 66. ADVANTAGECARE Company Information Table 67. ADVANTAGECARE Business Overview Table 68. ADVANTAGECARE Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. ADVANTAGECARE Third-Party Drug Testing Administration service Product Portfolio Table 70. ADVANTAGECARE Recent Development Table 71. CannAmm Company Information Table 72. CannAmm Business Overview Table 73. CannAmm Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. CannAmm Third-Party Drug Testing Administration service Product Portfolio Table 75. CannAmm Recent Development Table 76. Medway Company Information Table 77. Medway Business Overview Table 78. Medway Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Medway Third-Party Drug Testing Administration service Product Portfolio Table 80. Medway Recent Development Table 81. AMDT Company Information Table 82. AMDT Business Overview Table 83. AMDT Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. AMDT Third-Party Drug Testing Administration service Product Portfolio Table 85. AMDT Recent Development Table 86. WorkPlace Health Company Information Table 87. WorkPlace Health Business Overview Table 88. WorkPlace Health Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. WorkPlace Health Third-Party Drug Testing Administration service Product Portfolio Table 90. WorkPlace Health Recent Development Table 91. Global Verification Network Company Information Table 92. Global Verification Network Business Overview Table 93. Global Verification Network Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Global Verification Network Third-Party Drug Testing Administration service Product Portfolio Table 95. Global Verification Network Recent Development Table 96. Mobile Medical Corporation Company Information Table 97. Mobile Medical Corporation Business Overview Table 98. Mobile Medical Corporation Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Mobile Medical Corporation Third-Party Drug Testing Administration service Product Portfolio Table 100. Mobile Medical Corporation Recent Development Table 101. DRUG TESTING CORPORATION Company Information Table 102. DRUG TESTING CORPORATION Business Overview Table 103. DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Product Portfolio Table 105. DRUG TESTING CORPORATION Recent Development Table 106. Origin Company Information Table 107. Origin Business Overview Table 108. Origin Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Origin Third-Party Drug Testing Administration service Product Portfolio Table 110. Origin Recent Development Table 111. North America Third-Party Drug Testing Administration service Market Size by Type (2021-2026) & (US$ Million) Table 112. North America Third-Party Drug Testing Administration service Market Size by Type (2027-2032) & (US$ Million) Table 113. North America Third-Party Drug Testing Administration service Market Size by Application (2021-2026) & (US$ Million) Table 114. North America Third-Party Drug Testing Administration service Market Size by Application (2027-2032) & (US$ Million) Table 115. North America Third-Party Drug Testing Administration service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Third-Party Drug Testing Administration service Market Size by Country (2021-2026) Table 117. North America Third-Party Drug Testing Administration service Market Size by Country (2027-2032) Table 118. Europe Third-Party Drug Testing Administration service Market Size by Type (2021-2026) & (US$ Million) Table 119. Europe Third-Party Drug Testing Administration service Market Size by Type (2027-2032) & (US$ Million) Table 120. Europe Third-Party Drug Testing Administration service Market Size by Application (2021-2026) & (US$ Million) Table 121. Europe Third-Party Drug Testing Administration service Market Size by Application (2027-2032) & (US$ Million) Table 122. Europe Third-Party Drug Testing Administration service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Third-Party Drug Testing Administration service Market Size by Country (2021-2026) Table 124. Europe Third-Party Drug Testing Administration service Market Size by Country (2027-2032) Table 125. China Third-Party Drug Testing Administration service Market Size by Type (2021-2026) & (US$ Million) Table 126. China Third-Party Drug Testing Administration service Market Size by Type (2027-2032) & (US$ Million) Table 127. China Third-Party Drug Testing Administration service Market Size by Application (2021-2026) & (US$ Million) Table 128. China Third-Party Drug Testing Administration service Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Third-Party Drug Testing Administration service Market Size by Type (2021-2026) & (US$ Million) Table 130. Asia Third-Party Drug Testing Administration service Market Size by Type (2027-2032) & (US$ Million) Table 131. Asia Third-Party Drug Testing Administration service Market Size by Application (2021-2026) & (US$ Million) Table 132. Asia Third-Party Drug Testing Administration service Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Third-Party Drug Testing Administration service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Third-Party Drug Testing Administration service Market Size by Country (2021-2026) Table 135. Asia Third-Party Drug Testing Administration service Market Size by Country (2027-2032) Table 136. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Type (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Type (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Application (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Application (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2021-2026) Table 142. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Third-Party Drug Testing Administration service Product Image Figure 2. Global Third-Party Drug Testing Administration service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Third-Party Drug Testing Administration service Market Share by Type: 2025 VS 2032 Figure 4. Pre-Employment Drug Testing Image Figure 5. Reasonable Suspicion Drug Testing Image Figure 6. Random Drug Testing Image Figure 7. Return-to-Duty Drug Testing Image Figure 8. Post-Accident Drug Testing Image Figure 9. Others Image Figure 10. Global Third-Party Drug Testing Administration service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Third-Party Drug Testing Administration service Market Share by Application: 2025 VS 2032 Figure 12. SMEs Image Figure 13. Large Enterprise Image Figure 14. Global Third-Party Drug Testing Administration service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 16. Global Third-Party Drug Testing Administration service Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Third-Party Drug Testing Administration service Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Third-Party Drug Testing Administration service Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Third-Party Drug Testing Administration service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Third-Party Drug Testing Administration service Revenue Market Share by Type (2021-2032) Figure 23. Global Third-Party Drug Testing Administration service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Third-Party Drug Testing Administration service Revenue Market Share by Application (2021-2032) Figure 25. North America Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 26. North America Third-Party Drug Testing Administration service Market Share by Type (2021-2032) Figure 27. North America Third-Party Drug Testing Administration service Market Share by Application (2021-2032) Figure 28. North America Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 29. United States Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 30. Canada Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 32. Europe Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 33. Europe Third-Party Drug Testing Administration service Market Share by Type (2021-2032) Figure 34. Europe Third-Party Drug Testing Administration service Market Share by Application (2021-2032) Figure 35. Europe Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 36. Germany Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 37. France Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 39. Italy Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 40. Russia Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 42. China Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 43. China Third-Party Drug Testing Administration service Market Share by Type (2021-2032) Figure 44. China Third-Party Drug Testing Administration service Market Share by Application (2021-2032) Figure 45. Asia Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 46. Asia Third-Party Drug Testing Administration service Market Share by Type (2021-2032) Figure 47. Asia Third-Party Drug Testing Administration service Market Share by Application (2021-2032) Figure 48. Asia Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 49. Japan Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 53. India Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 54. Australia Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Third-Party Drug Testing Administration service Market Share by Country (2021-2032) Figure 59. Brazil Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 64. UAE Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 66. Chile Third-Party Drug Testing Administration service Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Pre-Employment Drug Testing
  • Reasonable Suspicion Drug Testing
  • Random Drug Testing
  • Return-to-Duty Drug Testing
  • Post-Accident Drug Testing
  • Others
Applications
  • SMEs
  • Large Enterprise
Companies covered
  • Lobdock
  • Info Cubic
  • Procom Testing
  • Midway
  • National Drug Screening
  • CO-OP Drug Testing
  • ADVANTAGECARE
  • CannAmm
  • Medway
  • AMDT
  • WorkPlace Health
  • Global Verification Network
  • Mobile Medical Corporation
  • DRUG TESTING CORPORATION
  • Origin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Third-Party Drug Testing Administration service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Pre-Employment Drug Testing
  5. 1.2.3 Reasonable Suspicion Drug Testing
  6. 1.2.4 Random Drug Testing
  7. 1.2.5 Return-to-Duty Drug Testing
  8. 1.2.6 Post-Accident Drug Testing
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Third-Party Drug Testing Administration service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 SMEs
  13. 1.3.3 Large Enterprise
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Third-Party Drug Testing Administration service Growth Trends by Region
  16. 1.5.1 Global Third-Party Drug Testing Administration service Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Third-Party Drug Testing Administration service Market Size by Region (2021-2026)
  18. 1.5.3 Third-Party Drug Testing Administration service Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Third-Party Drug Testing Administration service Market Dynamics
  1. 2.1 Third-Party Drug Testing Administration service Industry Trends
  2. 2.2 Third-Party Drug Testing Administration service Industry Drivers
  3. 2.3 Third-Party Drug Testing Administration service Industry Opportunities and Challenges
  4. 2.4 Third-Party Drug Testing Administration service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Third-Party Drug Testing Administration service Revenue by Company (2021-2026)
  2. 3.2 Global Third-Party Drug Testing Administration service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Third-Party Drug Testing Administration service Key Company Head office and Area Served
  4. 3.4 Global Third-Party Drug Testing Administration service Company, Product Type & Application
  5. 3.5 Global Third-Party Drug Testing Administration service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Third-Party Drug Testing Administration service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Third-Party Drug Testing Administration service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Third-Party Drug Testing Administration service Tier 1, Tier 2, and Tier 3
4 Third-Party Drug Testing Administration service Market by Type
  1. 4.1 Global Third-Party Drug Testing Administration service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Third-Party Drug Testing Administration service Market Size by Type (2021-2032)
  3. 4.3 Global Third-Party Drug Testing Administration service Market Size Share by Type (2021-2032)
5 Third-Party Drug Testing Administration service Market by Application
  1. 5.1 Global Third-Party Drug Testing Administration service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Third-Party Drug Testing Administration service Market Size by Application (2021-2032)
  3. 5.3 Global Third-Party Drug Testing Administration service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Lobdock
  2. 6.1.1 Lobdock Company Information
  3. 6.1.2 Lobdock Business Overview
  4. 6.1.3 Lobdock Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Lobdock Third-Party Drug Testing Administration service Product Portfolio
  6. 6.1.5 Lobdock Recent Developments
  7. 6.2 Info Cubic
  8. 6.2.1 Info Cubic Company Information
  9. 6.2.2 Info Cubic Business Overview
  10. 6.2.3 Info Cubic Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Info Cubic Third-Party Drug Testing Administration service Product Portfolio
  12. 6.2.5 Info Cubic Recent Developments
  13. 6.3 Procom Testing
  14. 6.3.1 Procom Testing Company Information
  15. 6.3.2 Procom Testing Business Overview
  16. 6.3.3 Procom Testing Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Procom Testing Third-Party Drug Testing Administration service Product Portfolio
  18. 6.3.5 Procom Testing Recent Developments
  19. 6.4 Midway
  20. 6.4.1 Midway Company Information
  21. 6.4.2 Midway Business Overview
  22. 6.4.3 Midway Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Midway Third-Party Drug Testing Administration service Product Portfolio
  24. 6.4.5 Midway Recent Developments
  25. 6.5 National Drug Screening
  26. 6.5.1 National Drug Screening Company Information
  27. 6.5.2 National Drug Screening Business Overview
  28. 6.5.3 National Drug Screening Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 National Drug Screening Third-Party Drug Testing Administration service Product Portfolio
  30. 6.5.5 National Drug Screening Recent Developments
  31. 6.6 CO-OP Drug Testing
  32. 6.6.1 CO-OP Drug Testing Company Information
  33. 6.6.2 CO-OP Drug Testing Business Overview
  34. 6.6.3 CO-OP Drug Testing Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 CO-OP Drug Testing Third-Party Drug Testing Administration service Product Portfolio
  36. 6.6.5 CO-OP Drug Testing Recent Developments
  37. 6.7 ADVANTAGECARE
  38. 6.7.1 ADVANTAGECARE Company Information
  39. 6.7.2 ADVANTAGECARE Business Overview
  40. 6.7.3 ADVANTAGECARE Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 ADVANTAGECARE Third-Party Drug Testing Administration service Product Portfolio
  42. 6.7.5 ADVANTAGECARE Recent Developments
  43. 6.8 CannAmm
  44. 6.8.1 CannAmm Company Information
  45. 6.8.2 CannAmm Business Overview
  46. 6.8.3 CannAmm Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 CannAmm Third-Party Drug Testing Administration service Product Portfolio
  48. 6.8.5 CannAmm Recent Developments
  49. 6.9 Medway
  50. 6.9.1 Medway Company Information
  51. 6.9.2 Medway Business Overview
  52. 6.9.3 Medway Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Medway Third-Party Drug Testing Administration service Product Portfolio
  54. 6.9.5 Medway Recent Developments
  55. 6.10 AMDT
  56. 6.10.1 AMDT Company Information
  57. 6.10.2 AMDT Business Overview
  58. 6.10.3 AMDT Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 AMDT Third-Party Drug Testing Administration service Product Portfolio
  60. 6.10.5 AMDT Recent Developments
  61. 6.11 WorkPlace Health
  62. 6.11.1 WorkPlace Health Company Information
  63. 6.11.2 WorkPlace Health Business Overview
  64. 6.11.3 WorkPlace Health Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 WorkPlace Health Third-Party Drug Testing Administration service Product Portfolio
  66. 6.11.5 WorkPlace Health Recent Developments
  67. 6.12 Global Verification Network
  68. 6.12.1 Global Verification Network Company Information
  69. 6.12.2 Global Verification Network Business Overview
  70. 6.12.3 Global Verification Network Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Global Verification Network Third-Party Drug Testing Administration service Product Portfolio
  72. 6.12.5 Global Verification Network Recent Developments
  73. 6.13 Mobile Medical Corporation
  74. 6.13.1 Mobile Medical Corporation Company Information
  75. 6.13.2 Mobile Medical Corporation Business Overview
  76. 6.13.3 Mobile Medical Corporation Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Mobile Medical Corporation Third-Party Drug Testing Administration service Product Portfolio
  78. 6.13.5 Mobile Medical Corporation Recent Developments
  79. 6.14 DRUG TESTING CORPORATION
  80. 6.14.1 DRUG TESTING CORPORATION Company Information
  81. 6.14.2 DRUG TESTING CORPORATION Business Overview
  82. 6.14.3 DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 DRUG TESTING CORPORATION Third-Party Drug Testing Administration service Product Portfolio
  84. 6.14.5 DRUG TESTING CORPORATION Recent Developments
  85. 6.15 Origin
  86. 6.15.1 Origin Company Information
  87. 6.15.2 Origin Business Overview
  88. 6.15.3 Origin Third-Party Drug Testing Administration service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Origin Third-Party Drug Testing Administration service Product Portfolio
  90. 6.15.5 Origin Recent Developments
7 North America
  1. 7.1 North America Third-Party Drug Testing Administration service Market Size (2021-2032)
  2. 7.2 North America Third-Party Drug Testing Administration service Market Size by Type
  3. 7.2.1 North America Third-Party Drug Testing Administration service Market Size by Type (2021-2026)
  4. 7.2.2 North America Third-Party Drug Testing Administration service Market Size by Type (2027-2032)
  5. 7.2.3 North America Third-Party Drug Testing Administration service Market Share by Type (2021-2032)
  6. 7.3 North America Third-Party Drug Testing Administration service Market Size by Application
  7. 7.3.1 North America Third-Party Drug Testing Administration service Market Size by Application (2021-2026)
  8. 7.3.2 North America Third-Party Drug Testing Administration service Market Size by Application (2027-2032)
  9. 7.3.3 North America Third-Party Drug Testing Administration service Market Share by Application (2021-2032)
  10. 7.4 North America Third-Party Drug Testing Administration service Market Size by Country
  11. 7.4.1 North America Third-Party Drug Testing Administration service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  13. 7.4.3 North America Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
  14. 7.4.4 North America Third-Party Drug Testing Administration service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Third-Party Drug Testing Administration service Market Size (2021-2032)
  2. 8.2 Europe Third-Party Drug Testing Administration service Market Size by Type
  3. 8.2.1 Europe Third-Party Drug Testing Administration service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Third-Party Drug Testing Administration service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Third-Party Drug Testing Administration service Market Share by Type (2021-2032)
  6. 8.3 Europe Third-Party Drug Testing Administration service Market Size by Application
  7. 8.3.1 Europe Third-Party Drug Testing Administration service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Third-Party Drug Testing Administration service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Third-Party Drug Testing Administration service Market Share by Application (2021-2032)
  10. 8.4 Europe Third-Party Drug Testing Administration service Market Size by Country
  11. 8.4.1 Europe Third-Party Drug Testing Administration service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Third-Party Drug Testing Administration service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Third-Party Drug Testing Administration service Market Size (2021-2032)
  2. 9.2 China Third-Party Drug Testing Administration service Market Size by Type
  3. 9.2.1 China Third-Party Drug Testing Administration service Market Size by Type (2021-2026)
  4. 9.2.2 China Third-Party Drug Testing Administration service Market Size by Type (2027-2032)
  5. 9.2.3 China Third-Party Drug Testing Administration service Market Share by Type (2021-2032)
  6. 9.3 China Third-Party Drug Testing Administration service Market Size by Application
  7. 9.3.1 China Third-Party Drug Testing Administration service Market Size by Application (2021-2026)
  8. 9.3.2 China Third-Party Drug Testing Administration service Market Size by Application (2027-2032)
  9. 9.3.3 China Third-Party Drug Testing Administration service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Third-Party Drug Testing Administration service Market Size (2021-2032)
  2. 10.2 Asia Third-Party Drug Testing Administration service Market Size by Type
  3. 10.2.1 Asia Third-Party Drug Testing Administration service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Third-Party Drug Testing Administration service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Third-Party Drug Testing Administration service Market Share by Type (2021-2032)
  6. 10.3 Asia Third-Party Drug Testing Administration service Market Size by Application
  7. 10.3.1 Asia Third-Party Drug Testing Administration service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Third-Party Drug Testing Administration service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Third-Party Drug Testing Administration service Market Share by Application (2021-2032)
  10. 10.4 Asia Third-Party Drug Testing Administration service Market Size by Country
  11. 10.4.1 Asia Third-Party Drug Testing Administration service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Third-Party Drug Testing Administration service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Third-Party Drug Testing Administration service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst